A class-action trial in Australia is causing great controversy by revealing that a number of fake medical journals were published to post favourable results for the drug Vioxx.
The publications, sponsored by Merck (the producer of Vioxx), had prestigious sounding-names like "The Australian Journal of Bone and Joint Medicine." Names of doctors, who had never agreed to be involved, are listed in the publication as honorary board members. These fake journals were supposed to provide independent studies on the drug.
It is alleged that this was part of Merck's misleading sales strategy in promoting Vioxx.
Technorati Tags: vioxx, fake vioxx journals, australian class-action, Merck
The publications, sponsored by Merck (the producer of Vioxx), had prestigious sounding-names like "The Australian Journal of Bone and Joint Medicine." Names of doctors, who had never agreed to be involved, are listed in the publication as honorary board members. These fake journals were supposed to provide independent studies on the drug.
It is alleged that this was part of Merck's misleading sales strategy in promoting Vioxx.
Technorati Tags: vioxx, fake vioxx journals, australian class-action, Merck
No comments:
Post a Comment